Neo7Bioscience’s success depends on our ability to collaborate with suppliers worldwide. As part of our procurement and supply-chain strategy, we employ responsible sourcing, supplier inclusion, auditing procedures, green chemistry and sustainable manufacturing and distribution principles to minimize the impact from our procurement and supply chain practices.
We are committed to working with suppliers that share our values related to social, economic and environmental performance. If your company is able to demonstrate your ability to provide quality goods and services at a fair price and commitment to social and environmental responsibilities, we welcome the opportunity to work with you and include you in our success story.
Neo7Bioscience uses a combination of company owned facilities and strategic third-party partners to manufacture and distribute products worldwide. We are dedicated to reducing the environmental impact associated with manufacturing our products.
Neo7Bioscience’s suppliers for active pharmaceutical ingredients (APIs) and drug products must observe GMP regulations as required by the FDA and other relevant health authorities worldwide. GMP covers all aspects of production including manufacturing procedures, testing methods, maintenance of premises and equipment, training, personal hygiene of staff and appropriate documentation.